Independent analysis puts a TFC mazdutide lot at 98.4%, against 95.9% on the certificate
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.
Archive — September 2024
Page 3 of 5 of this archive, newest first.
Norway declines to reimburse semaglutide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
What the trials monitored, and what that implies about routine practice
Timing is the whole of the post-cessation panel: draw it too early and it measures the treatment period.
The tolerability data everybody quotes and nobody reads
Trial adverse-event tables count episodes reported to a study nurse. They are the best data we have and they systematically under-record the mundane.
What a 40% rise in coupling-reagent prices does to a 20 mg vial
Follow the resin, not the catalogue.
Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.
The consolidator trading as Meridian Freight Partners closes after 6 years
A proper account of an operation that existed, and of what closing it cost.
Quadrupole, time-of-flight, orbital trap: what each class can and cannot see
Every instrument specification quoted in an advertisement is a best case obtained on a calibration mixture, not on a submitted vial.
Twelve minutes or forty: what gradient slope buys
A shallow gradient resolves impurities that a steep one runs into the parent peak. Both methods are legitimate; only one of them can see the small stuff.
HJ declines, for the 13th time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Nigeria health authority warns on falsified exenatide pens
Reported from the analysis, not from a warning notice.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
A shortage listing ends. 22 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
The lead-in, the randomisation, and the year that followed
The regain trajectories, arm by arm, with the estimands named.
Which results are findings and which are consequences of the weight loss
The panel drawn during a week of vomiting is measuring the vomiting.
Why a result on one vial says less than the trade needs it to
The condition on arrival is recorded by some services and not others, and it is one of the more informative lines in a report.
Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.
STEP 2 extension data: what happens after the trial stops
A design note rather than a result: what the comparator was, and what that permits you to conclude.
Norway pharmacy body issues counselling standards for tirzepatide initiation
The evidence base is thin and the document says so, which is to its credit.
Halvard & Pike Apothecary of Portland, Maine enters a consent decree and stops sterile preparation
The observation that closes a facility is rarely the dramatic one.
The certificate of analysis, line by line
The purity figure is the least informative line on a well-constructed certificate and the only line most buyers read.
Japan health authority warns on falsified tirzepatide pens
Reported from the analysis, not from a warning notice.
HJ declines, for the 17th time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The 7-day notice: how a compounding wind-down works in the United Kingdom
The document is four pages. Three of them are about dates.
From the floor in Zhuhai: 20 posters, one theme
Reported from the sessions, and from the two hours afterwards.
The fourteen-day problem, and what it does to a commercial testing model
The absence of microbiological capability in this market is a commercial fact with a straightforward explanation, and it is worth understanding before blaming anybody for it.
Weight regain is not a failure of willpower and it is not a mystery
Regain begins immediately, proceeds at a decelerating rate, and does not usually return to baseline within the observed follow-up. Each of those three clauses matters.
Halvard & Pike Apothecary of Portland, Maine enters a consent decree and stops sterile preparation
The observation that closes a facility is rarely the dramatic one.
A supplier suspends shipping to New Zealand after 6 consecutive customs detentions
The route did not close because of a rule about peptides.
A shortage listing ends. 12 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
Target dose, effective dose, and the distance between them
The dose-response curve in this class flattens near its top. That has direct consequences for whether the final rung is worth climbing.
Longer is not safer
The insulin injection-technique literature is large, well conducted and directly transferable on questions of depth and tissue. We say where it stops transferring.
Amylin is not an incretin, and cagrilintide is not a GLP-1 agonist
The glucagon arm raises energy expenditure and also raises hepatic glucose output. Balancing those is the whole engineering problem.
The 6-day notice: how a compounding wind-down works in Turkey
The document is four pages. Three of them are about dates.
What changed at ERP in September, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
VendorInvestigate result on a Suzhou liraglutide lot lands 4.2 points below the supplier’s figure
The report states the gradient, the wavelength and the integration threshold, which is more than most.
Peak capacity, and the honest measure of a separation
Column chemistry, particle size and pore diameter determine what the separation is capable of before the gradient is even programmed.
A supplier suspends shipping to Japan after 12 consecutive customs detentions
The route did not close because of a rule about peptides.
Xianning export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.